Clinical Trials Directory

Trials / Unknown

UnknownNCT03862599

Low Intensity Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy

Low Intensity Extracorporeal Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Guy's and St Thomas' NHS Foundation Trust · Academic / Other
Sex
Male
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. A few small studies have recently shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery.

Detailed description

Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. At present, this debilitating consequence of surgery is managed in a step-wise approach including oral medication, injections and in severe cases, insertion of a penile prosthesis. A few small studies have shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery. Low-intensity shockwave therapy would be a non-invasive treatment to preserve and improve patient's sexual function.

Conditions

Interventions

TypeNameDescription
DEVICEExtra-corporeal shockwave therapy (ESWT)low-intensity extra-corporeal shockwave therapy
OTHERStandard careCialis and vacuum pump

Timeline

Start date
2021-06-01
Primary completion
2024-10-01
Completion
2025-05-01
First posted
2019-03-05
Last updated
2023-03-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03862599. Inclusion in this directory is not an endorsement.